Continuing my superlatives title theme from last week, I’m taking here a look at the very largest company by market capitalisation, BP (LSE: BP). BP has a cap of around £122bn, somewhat ahead of second placed HSBC (LSE: HSBA) on £109bn and substantially in front of third placed Glaxosmithkline (LSE: GSK) on a mere £83bn.
Does size matter? For value players, sometimes it does, but not when we’re talking this sort of size. I’ve said before that for a value play, other things being equal, I’d always prefer a larger cap to a smaller….
Continue reading this article at the Motley Fool